Saint Louis, MO · Founded 2011 · Privately Held (backing)
Developer of fluorescent tracer-agent-based systems designed to help provide a vital and actionable measurement of organ function. MediBeacon is based in Saint Louis, MO and was founded in 2011. Its last reported valuation was $300 million in Sep 2019. It has raised $111 million across 10 recorded rounds; the latest was a $16.1 million early-stage round in Aug 2023.
Last reported valuation
$300.0M
Oct 2026
Priced at
—
Total raised
$110.6M
Last round
Early Stage VC
Aug 2023
Cap table — not yet on record
MediBeacon's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of MediBeacon with a free account
·The complete investor list: 16 names
·Watch MediBeacon: the Monday email on marks, rounds and moves